Category Archives: Pr Newswire

ROCKVILLE, Md. and SUZHOU, China, April 19, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it will present four preclinical studies in poster format […]

STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing solid tumor PDX models, with improved efficacy versus benchmark ADCs STRO-006 and STRO-227 show meaningful, dose-dependent antitumor activity across solid tumor models Presentation of TROP2-targeted immunostimulatory ADC program partnered with Astellas highlights the potential of Sutro’s platform for developing dual-payload ADCs SOUTH SAN FRANCISCO, Calif., […]

WILMETTE, Ill., April 19, 2026 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, announced new analyses from the randomized controlled Phase 3 FoCus trial of ALXN1840 (tiomolibdate choline, TMC) showing greater neurologic benefit versus standard of care (SoC) […]

Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time points X-TOLE2 data featured in Late-breaking Science session show 53.2% reduction in monthly seizure frequency in 25 mg group vs. 10.4% for placebo and increasing rates of 100% seizure reduction over time during 12-week double-blind period Long-term data from the ongoing […]

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma OS benefit observed across key subgroups, including patients with high tumor burden, elevated LDH, and extrahepatic disease as well as those with best response of progressive disease This is the longest OS follow-up in a randomized […]

–     Mass production of 192GB high capacity products designed for the NVIDIA Vera Rubin platform–     Maximizes power efficiency by featuring high density DRAM based on the latest 1cnm process–     Company to closely collaborate with NVIDIA to solve bottlenecks in AI infrastructure and provide optimal performance SEOUL, South Korea, April 20, 2026 /PRNewswire/ — SK hynix Inc. […]

SYDNEY, April 20, 2026 /PRNewswire/ — Tineco, the world’s #1 leader in wet and dry hard floor cleaning, has today announced details of its Autumn Amazon sale commencing today, delivering Australians up to 56% off world-leading floorcare technology that makes it easier than ever to ditch the mop and bucket and upgrade the cleaning routine to […]

Order value of approximately USD 68M with mass production to begin in 2027 Offering data transmission speed three times faster, with no speed degradation even with multiple devices connected simultaneously Changing perception of car considered as ‘a second living space’…Trend enhancing growth of Automotive Wi-Fi market, expected to grow 9.6% annually SEOUL, South Korea, April […]

LAS VEGAS, April 20, 2026 /PRNewswire/ — SIRUI today received a “Best of Show” award for its Vision Prime T1.4 Full-Frame Cine Lens Series, while also introducing new focal lengths for both the Vision Prime and IronStar lens families at the 2026 NAB Show. The expanded lineups give filmmakers a more complete range of creative […]

•  The one-year INFUSE study observed patient-reported migraine-related cognitive symptoms at baseline and changes over 6 months in those with at least one prior anti-calcitonin gene-related peptide (anti-CGRP) treatment failure VALBY, Denmark, April 20, 2026 /PRNewswire/ — H. Lundbeck A/S (Lundbeck) today presented new real-world 6-month results from the INFUSE study at the American Academy of […]